SCHEMBL19651995

SCHEMBL19651995

Cc1c(C(N)=O)ccn(C)c1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT3 Q9NTG7 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
BRD4 O60885 4/20 0.38
BRD9 Q9H8M2 2/20 0.38
KDM4E B2RXH2 4/20 0.37
KDM6A O15550 1/20 0.37
KDM4A O75164 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
KDM5C P41229 1/20 0.37
KDM2B Q8NHM5 1/20 0.37
DOHH Q9BU89 1/20 0.37
KDM2A Q9Y2K7 1/20 0.37
PARP1 P09874 1/20 0.36
MAP2K1 Q02750 3/20 0.35
MAP2K2 P36507 2/20 0.35
BRPF1 P55201 2/20 0.34
TAF1 P21675 1/20 0.34
CREBBP Q92793 1/20 0.34
CECR2 Q9BXF3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19726699 0.81 CYP2C9 (0.37) BRD4BRD9KDM4EKDM6AKDM4A
SCHEMBL3061744 0.81 LIPG (0.45) BRD4BRD9KDM4EKDM6AKDM4A
SCHEMBL1384364 0.78 KDM4E (0.45) SIRT3TDP1BRD4BRD9KDM4E
SCHEMBL4649779 0.74 BRD4 (0.42) SIRT3TDP1BRD4BRD9KDM4E
SCHEMBL9614829 0.74 KDM4E (0.44) KDM4EPARP1MAP2K1MAP2K2IRAK4
SCHEMBL12677164 0.74 BRD4 (0.42) BRD4BRD9KDM4EPARP1MAP2K1
SCHEMBL25072434 0.74 KDM4E (0.35) SIRT3TDP1KDM4EKDM6AKDM4A
SCHEMBL20516021 0.72 BRD4 (0.41) BRD4BRD9KDM4EMAP2K1MAP2K2
SCHEMBL22723993 0.72 BRD4 (0.50) BRD4KDM4EPARP1ALDH1A1L3MBTL1
SCHEMBL1018603 0.71 NNMT (0.47) SIRT3TDP1BRD4KDM4EPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170340759-A1 RADIO-PHARMACEUTICAL COMPLEXES BAYER AS (NO) 2017-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170340759-A1 RADIO-PHARMACEUTICAL COMPLEXES PTMS, THOP1, PHPT1 SIRT3 1934/4885TDP1 765/4885BRD4 3547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.